|
Company Description
Luminex Corporation was incorporated in May 1995 and began commercial production of our first generation system in 1997. Luminex® (NASDAQ: LMNX) develops, manufactures and markets innovative biological testing technologies with applications throughout the life science and diagnostic industries. The company’s open-architecture xMAP® technology enables large numbers of biological tests (bioassays) to be conducted and analyzed quickly, cost-effectively and accurately.
Systems using xMAP technology perform discrete bioassays on the surface of color-coded beads known as microspheres, which are then read in a compact analyzer. Using lasers and high-speed digital-signal processors, the analyzer simultaneously identifies the bioassay and measures the results, all in real time.
Luminex Vision Statement
Worldwide Leader in Multiplexed Solutions
Career Opportunities
Luminex is always looking for a few good people.
Read the job listings. Submit a resume.
Visitor Information
Find out how to get to Luminex and where to stay.
Investor Relations
Luminex is a publicly traded company on the NASDAQ Stock Market under the symbol “LMNX".
Events
Learn more about the exhibitions and conferences Luminex will attend.
|
|
